The hope for a new era in Parkinson's treatment: CDNF in focus

The world of medicine may be on the verge of a revolutionary development in the fight against Parkinson's disease, thanks to the discovery and research surrounding a special protein known as Cerebral Dopamine Neurotrophic Factor (CDNF). This development could not only improve the living standards of millions of those affected, but also offer a new way to treat neurodegenerative diseases.

The skin as a mirror of the brain

We all know the skin as the largest organ in our body - it protects us, regulates temperature and enables touch. But did you know that the skin can now also provide insights into the interior of our nervous system? Boston researchers have found that a protein called phosphorylated alpha-synuclein, which plays a key role in Parkinson's disease and other neurodegenerative diseases, can also be detected in the skin. This exciting discovery opens new avenues for diagnosing Parkinson's and related diseases.

Detect Parkinson's early, delay it, stop it or prevent it

In his lecture “Detect, delay, stop or prevent Parkinson’s disease early” Professor Oertel shares his extensive knowledge and many years of experience with us. Parkinson's disease, a progressive neurodegenerative disease, affects millions of people worldwide. Despite intensive research and development in treatment, it remains a major challenge for patients, families and healthcare professionals.

Professor Oertel will walk us through the latest findings that not only aim to detect the disease in its earliest stages, but also present strategies and therapies that can delay or even stop its progression. He will also discuss preventative measures that could reduce the risk of developing Parkinson's disease.

This lecture is aimed at anyone interested in Parkinson's disease and its impact on the lives of those affected. Prepare for an insightful session that will shed light on the darkness of this disease and offer hope for new avenues in its treatment and prevention.

Parkinson's and environment, the unknown risk factor

The recognition of Parkinson's syndrome caused by pesticides as an occupational disease represents a significant advance in the understanding and treatment of this neurodegenerative disease. This development is not only relevant for farmers, but also has far-reaching significance for all people who suffer from Parkinson's disease or have one carry an increased risk of the disease. It signals an increasing recognition of environmental factors, particularly exposure to certain chemicals, as possible triggers for Parkinson's.

Cannabis legalization and Parkinson's disease. Advantages and disadvantages

The discussion about the use of medical cannabis to treat various diseases has increased worldwide in recent years. The potential of cannabis-based therapies is being intensively researched, particularly for Parkinson's disease, a neurodegenerative disease that affects millions of people.

Aspiration pneumonia and Parkinson's disease

Aspiration pneumonia is considered one of the three most likely causes of death in Parkinson's disease, so as frightening as it may be, it is important to know about it. This type of pneumonia occurs when food or drink enters the lungs. How can this happen? There are two ways: Firstly, while eating or drinking, when some of the food or liquid consumed goes “down the wrong tube”, which leads to coughing. If the cough is not enough, food and fluid can enter the lungs.

Eating and drinking for Parkinson's disease - a lecture by Prof. Dr. Ceballos Baumann

Food and drink play a central role in everyone's daily life, but for people living with Parkinson's they can present a number of challenges. In the following lecture we will look at how eating habits can be adjusted to ensure a balanced diet and improve quality of life. Our goal is to develop a deeper understanding of the importance of an adapted diet in Parkinson's disease and to show ways in which enjoyment of eating and drinking can be maintained despite the disease.

Between technical jargon and patient understanding: The hurdles of medical communication

Communication between doctors and patients is a fundamental aspect of healthcare that is often complicated by a seemingly insurmountable barrier: technical language. While doctors juggle complex terminology every day, patients often reach their limits when it comes to understanding medical information. This mismatch between jargon and patient understanding represents a serious barrier to effective healthcare.

The study of dopamine, serotonin and social behavior

The neurotransmitters dopamine and serotonin in the brain have a significant influence on our social behavior, as new research shows. For the first time, their interaction has been directly observed thanks to the participation of four Parkinson's patients in an experiment during brain surgery. The results reveal a neurochemical mechanism that explains our tendency to make decisions in a social context. Additionally, in the long term, this technique could help to better understand changes in brain chemistry associated with Parkinson's disease.


Therapeutic fasting is absolutely trendy and I had already heard and read a lot about it. Our entire "system" has been geared towards longer phases "without food" from the very beginning. Nowadays, however, people eat almost continuously, whether because of hunger, appetite, boredom, grief or frustration, etc. The food industry does not necessarily serve us what counts as a balanced diet. Flavor enhancers, dyes, emulsifiers, preservatives, sugar, fast food and the like make us ill in the long run and we slowly develop food allergies and inflammatory processes in the body. I wanted to give my body a break from it and be surprised by the positive effects of therapeutic fasting despite or precisely because of my previous illnesses (ulcerative colitis and Parkinson's disease).